Cargando…
Management of Patients With Skin Cancers: Basal Cell Carcinoma and Melanoma
Novel therapies are changing the treatment paradigm for both melanoma and advanced/metastatic basal cell carcinoma. While immunotherapies are increasing survival benefits in melanoma, they are associated with unique immune-related adverse events.
Autores principales: | Hoffner, Brianna, Siegel, Daniel M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Harborside Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6003758/ https://www.ncbi.nlm.nih.gov/pubmed/29928546 |
Ejemplares similares
-
Trametinib: A Targeted Therapy in Metastatic Melanoma
por: Hoffner, Brianna, et al.
Publicado: (2018) -
Evolving Paradigms in Melanoma Therapy
por: Olszanski, Anthony J., et al.
Publicado: (2016) -
Novel Approaches in Non-Melanoma Skin Cancers—A Focus on Hedgehog Pathway in Basal Cell Carcinoma (BCC)
por: Chmiel, Paulina, et al.
Publicado: (2022) -
Basal cell carcinoma, squamous cell carcinoma and melanoma of the head and face
por: Feller, L., et al.
Publicado: (2016) -
Managing Side Effects of Cancer Patients Treated With Immunotherapy
por: Hoffner, Brianna, et al.
Publicado: (2018)